Results 121 to 130 of about 6,860 (236)

Antimicrobial Activity of Doripenem Tested Against Leading Bacterial Pathogens: Results from a Latin American Surveillance Study (2003-2006)

, 2008
Carbapenems have been the therapeutic choice for empirical treatment of serious infections when multidrug-resistant Gram-negative organisms are suspected.
Gales, Ana Cristina [UNIFESP], Sader, Helio Silva [UNIFESP], Fritsche, Thomas R., Jones, Ronald N.   +3 more
core  

Doripenem: An expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens

, 2008
Background: Potent new drugs against multidrug-resistant Gram-negative bacteria, namely Pseudomonas aeruginosa and Acinetobacter spp. and pan-drug-resistant Klebsiella pneumoniae, which constitute an increasing medical threat, are almost absent from the ...
Giamarellou, H., Poulakou, G.
core  

Citrobacter freundii multirresistente como agente etiológico de infección de vías urinarias

Kasmera, 2019
: Citrobacter freundii, sometimes it can act as opportunistic pathogen, a case of this isolated microorganism is presented as an etiological agent of urinary tract infection, in a patient with chronic obstructive pulmonary disease.
Ullauri-González, Carmen, Freire-Cuesta, Sandra.   +1 more
doaj  

Adsorption kinetics of amoxicillin, ampicillin, and doripenem on organobentonite

THE 7TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: The 15th Asian Congress on Biotechnology in conjunction with the 7th International Symposium on Biomedical Engineering (ACB-ISBE 2022)
Jason Yi Juang Yeo, A. Aqsha, S. Ismadji, J. Sunarso   +3 more
semanticscholar   +1 more source

Synergistic activity of dual β-lactams against <i>Mycobacterium avium</i> complex. [PDF]

Microbiol Spectr
Shin E, Dousa KM, Nantongo M, Kurz SG, Holland SM, Kreiswirth BN, Bonomo RA.   +6 more
europepmc   +1 more source

A multi-stage computational pipeline for repurposing FDA-approved drugs: application to EGFR C797S-mutant NSCLC. [PDF]

Front Chem
Alturki MS, Alkhodier RA, Al Khzem AH, Almuzaini OK, Wali SM, Aldosarry KN, Halawi AA, Aldawsari MF, Alruwili WR, Gomaa MS.   +9 more
europepmc   +1 more source

Enzymatic activity of PBP1B is required for growth rate-independent ppGpp-mediated resistance to PBP2 inhibitors in E. coli. [PDF]

J Bacteriol
Anderson SE, Mack IE, Levin PA.
europepmc   +1 more source

A Case of Mediastinitis Due to Fulminant Group A Streptococcal Infection. [PDF]

Surg Case Rep
Abe Y, Haratake N, Sato T, Abe M, Takumi Y, Sugio K, Osoegawa A.   +6 more
europepmc   +1 more source

In vitro Screening for Synergistic Polymyxin B-Based Combinations Against KPC- Producing Carbapenem-Resistant <i>Klebsiella pneumoniae</i>. [PDF]

Drug Des Devel Ther
Lv M, Yi H, Liu Y, Xie Y, Cheng Z, Xie F, Li S.   +6 more
europepmc   +1 more source

Impact of an infectious disease specialist-led antimicrobial stewardship program and consultations during multiple antimicrobial shortages: A bayesian structural time-series analysis. [PDF]

PLoS One
Itoh N, Okumura N, Akazawa-Kai N, Wachino C, Kuriki S, Kawabata T.   +5 more
europepmc   +1 more source